HomeIPO List › Tempsens Instruments

Closed — Awaiting Allotment

Tempsens Instruments IPO GMP, Price & Allotment Status

Tempsens Instruments is India's largest manufacturer of contact and non-contact temperature sensors by revenue, holding roughly 10.5% market share, and also makes electrical heating solutions and specialised cables for process industries.

Advertisement

Latest Grey Market Premium

GMP₹313
Implied Premium+104.33%
As Of2026-08-24

GMP is an unofficial, unregulated grey-market indicator — not recognised by SEBI, NSE or BSE, and it can change quickly. Don't treat it as a guaranteed listing price.

Key Details

Issue Size₹650 crore
Price Band₹285 – ₹300
Lot Size50 shares
Open Date2026-08-20
Close Date2026-08-24
Allotment Date2026-08-25
Listing Date2026-08-28
Registrar KFin Technologies

Subscription Status

Retail18.73x
NII / HNI52.98x
QIB3.31x
Overall21.69x

GMP History

DateGMPImplied Premium
2026-08-24 ₹313 +104.33%
2026-08-24 ₹300 +100%
2026-08-21 ₹277 +92%
2026-08-17 ₹154 +51%

Frequently Asked Questions

What does Tempsens Instruments do?

Tempsens is India's largest maker of contact and non-contact temperature sensors by revenue (about 10.5% market share), and also makes electrical heating solutions and specialised cables for industrial process customers.

What is the Tempsens Instruments IPO price band and lot size?

The price band is ₹285 to ₹300 per share. The minimum lot is 50 shares, so a retail investor needs about ₹15,000 to apply for one lot at the upper band.

What is Tempsens Instruments IPO's GMP and what does it imply?

GMP climbed sharply through the week — from ₹154 (51%) on August 17 to ₹313 (104%) by the final subscription day, August 24. That implies a listing price near ₹613, though GMP is an unofficial, unregulated indicator and the actual listing price can differ meaningfully.

Was Tempsens Instruments IPO oversubscribed?

Yes — the issue was subscribed 21.69 times overall, with the non-institutional (NII) portion leading at 52.98 times and retail at 18.73 times.

Should you apply for Tempsens Instruments IPO? What do brokerages say?

Anand Rathi rated it 'Subscribe – Long Term', citing revenue growth and international expansion, while also flagging that the valuation at the upper price band leaves limited room for error. KC Securities also recommended subscribing. As with any IPO, strong GMP and brokerage support aren't guarantees — weigh the valuation (P/E near 35x) against your own risk tolerance.

Last updated 2026-08-24T07:20:00+05:30 · See what else is trending · Full IPO List